Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers from the CIMA of the University of Navarra have discovered a possible cause of thrombosis

16.01.2007
A team of researchers from the CIMA of the University of Navarra has discovered a possible cause of thrombosis, and has developed a new diagnostic test for this disease.

The scientific project was undertaken in the Hemostasis and Thrombosis Laboratory. Based on this advance, Digna Biotech, the biotechnology firm that develops the patents obtained by the CIMA, has signed an agreement with the pharmaceutical firm Ferrer Internacional. This alliance will permit the commercialization, perhaps this year, of the new diagnostic test.

Thrombosis is a disease provoked by the appearance of a thrombus or blood clot, which totally or partially blocks the flow of blood. This pathology constitutes one of the principal causes of death. The researchers from the area of Cardiovascular Sciences of the CIMA base the new diagnostic test on the detection of EPCR antibodies, a substance that protects the blood vessels against obstruction by a thrombus.

Useful for young women suffering heart attack or multiple miscarriages

... more about:
»CIMA »Navarra »thrombosis

At the moment, this diagnostic test may be useful in the treatment of young women who have suffered a myocardial infarction or who have suffered multiple miscarriages due to thrombosis in the placenta. Research is continuing concerning other pathologies, where the biological basis of the disease is thrombosis, such as strokes and pulmonary embolisms. In the future, the new test may serve to design more effective antithrombotic treatments.

The project’s scientists explained that the C protein system constitutes one of the principal mechanisms for avoiding thrombosis in humans, and that the presence of the endothelial protein receptor C (EPCR) is necessary for its correct functioning. The researchers from the CIMA of the University of Navarra have demonstrated the existence of anti-EPCR autoantibodies which impede the antithrombotic function of this system. In addition, they have demonstrated that elevated levels of anti-EPCR antibodies in the serum and plasma of the patients is related to an increased risk of suffering new thrombotic phenomena.

Irati Kortabitarte | alfa
Further information:
http://www.basqueresearch.com/berria_irakurri.asp?Gelaxka=1_1&hizk=I&Berri_Kod=1149

Further reports about: CIMA Navarra thrombosis

More articles from Life Sciences:

nachricht ADP-ribosylation on the right track
26.04.2018 | Max-Planck-Institut für Biologie des Alterns

nachricht Flavins keep a handy helper in their pocket
25.04.2018 | University of Freiburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Why we need erasable MRI scans

New technology could allow an MRI contrast agent to 'blink off,' helping doctors diagnose disease

Magnetic resonance imaging, or MRI, is a widely used medical tool for taking pictures of the insides of our body. One way to make MRI scans easier to read is...

Im Focus: BAM@Hannover Messe: innovative 3D printing method for space flight

At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.

Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Why we need erasable MRI scans

26.04.2018 | Medical Engineering

Balancing nuclear and renewable energy

26.04.2018 | Power and Electrical Engineering

Researchers 3-D print electronics and cells directly on skin

26.04.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>